Biography

As a Master's Degree Supervisor, WU Qi has been engaged in research related to pulmonary fibrosis diseases for many years. His work has led to the publication of over 20 SCI papers. He has hosted a project funded by the National Natural Science Foundation of China’s Youth Fund.

2013 – 2015    Institution: Peking University Medical Lu Zhong Hospital

2018 – Present Institution: Xuzhou Medical University, Basic Medical College

Education

Ph.D. in Integrative Medicine

Nanjing University of Chinese Medicine, September 2015 - June 2018

Supervisor: Zhou Xianmei

Master's in Internal Medicine

Guilin Medical University, September 2010 - June 2013

Clinical Medicine

Jining Medical University, September 2008 - June 2010

Publications

Representative publications: 

1. Wang D, Xu Y, Huang T, Peng W, Zhu D, Zhou X, Wu Q. Clinical efficacy and safety of NSCLC ancillary treatment with compound Kushen injection through immunocompetence regulation: A systematic review and meta-analysis. Phytomedicine. 2022 Sep;104:154315.

2. Xu Y, Hang WL, Zhou XM, Wu Q. Exploring the Mechanism Whereby Sinensetin Delays the Progression of Pulmonary Fibrosis Based on Network Pharmacology and Pulmonary Fibrosis Models. Front Pharmacol. 2021;12:693061.

3. Wu Q, Zhang KJ, Jiang SM, et al. p53: A Key Protein That Regulates Pulmonary Fibrosis. Oxid Med Cell Longev. 2020;2020:6635794.

4. Wu Q, Xu Y, Zhang KJ, Jiang SM, Zhou Y, Zhao Y. A Clinical Model for the Prediction of Acute Exacerbation Risk in Patients with Idiopathic Pulmonary Fibrosis. Biomed Res Int. 2020;2020:8848919.

5. Peng W, Xu Y, Han D, Feng F, Wang Z, Gu C, Zhou X, Wu Q. Potential mechanism underlying the effect of matrine on COVID-19 patients revealed through network pharmacological approaches and molecular docking analysis. Arch Physiol Biochem. 2023 Feb;129(1):253-260.

6. Wu Q, Guan YB, Zhang KJ, Li L, Zhou Y. Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis. J Ethnopharmacol. 2023;316:116667.

7.Zhang K, Li M, Yin K, Wang M, Dong Q, Miao Z, Guan Y, Wu Q, Zhou Y. Hyperoside mediates protection from diabetes kidney disease by regulating ROS-ERK signaling pathway and pyroptosis. Phytother Res. 2023 Dec;37(12):5871-5882.